Demand for minimally invasive procedures and better healthcare infrastructure along with the increase in the competition, has led to technological advancements and innovations in Thrombectomy Devices Market.

Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. These are carefully designed to minimize damage to the vessel wall during a procedure, with the minimum blood loss. They are available in different sizes and diameters and depending on the affected area, the required catheter is chosen. These devices are used to treat acute myocardial infarction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

Get the sample report: https://www.alliedmarketresearch.com/request-sample/1608?utm_source=openpr&utm_medium=Niranjan

Thrombectomy Devices Market Report, published by Allied Market Research, forecasts that the global market was valued at $982 million in 2016, and is expected to reach $1,389 million by 2022, supported by a CAGR of 5.9% during the forecast period 2014 to 2022.

Mechanical thrombectomy would continue to be the preferred technology throughout the analysis period. North America dominated with around half of the market share in 2015 and is projected to maintain the lead throughout the forecast period.

High occurrences of acute myocardial infarction, peripheral artery disease, deep vein thrombosis, VTE (Venous Thromboembolism) and pulmonary embolism owing to the sedentary, and unhealthy lifestyle majorly drive the market growth. VTE is most common in adults (>60 years). In addition, better healthcare infrastructure and increase in demand for minimally-invasive treatments; rise in the geriatric population, which increases the incidence of cardiovascular diseases; and technological advancements & innovations are the factors that nurture the growth of the thrombectomy devices market. Some of the restraints associated with the thrombectomy devices market are a scarcity of trained professionals, lack of awareness, and the complicated use of devices.

Purchase the report @Discount: https://www.alliedmarketresearch.com/checkout/721731?utm_source=openpr&utm_medium=Niranjan

Disposable thrombectomy devices segment generated the highest revenue in 2015 and would continue to follow this trend throughout the analysis period.

Geographically, North America occupied a major market share in 2015, and is expected to continue leading during the analysis period. This was attributed to the sedentary and unhealthy lifestyle of the current generation, the demand for better healthcare infrastructure, an increase in demand for minimally-invasive treatments and incidence of cardiovascular diseases. However, Asia-Pacific followed by LAMEA are expected to be the fastest growing regions, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of thrombus.

The thrombectomy devices market holds a substantial scope for growth globally. Recent innovations, which embed the introduction of innovative ideas such as the use of lasers, ultraviolet radiation, and 3D image generation, will provide better results to the physicians and allow them to work more efficiently. The upcoming trend in this market is the introduction of a technique, which involves the combination of decompressive hemicraniectomy and endovascular thrombectomy to treat patients with cerebral venous thrombosis.

Key findings of the Thrombectomy Devices Market
• Mechanical thrombectomy devices were the leading segment in 2015 and are expected to maintain this position throughout the analysis period.
• The neurovascular disorder is the major indication which uses thrombectomy devices for treatment; with over half of the total market share in 2015.
• Peripheral and coronary diseases segments are projected to grow at a significant CAGR.
• Reusable thrombectomy devices are projected to grow at a CAGR of 7.7%.
• U.S market for thrombectomy devices is projected to grow at a CAGR of 5.0%.
• The U.S. was the largest country market in 2015 and is projected to maintain its lead until 2022.

Key players have adopted mergers & acquisitions and product launch as their key strategies in the thrombectomy devices market. This is due to the growth in competition and continuous technological advancements. In July 2016, Penumbra launched thrombectomy device ACE 68 Reperfusion Catheter for commercial use in the U.S. This catheter uses the latest advancements available in the tracking technology and delivers maximum aspiration power for extracting thrombus in stroke intervention. This product launch is expected to strengthen the product portfolio of Penumbra, a leading market player.

The major market players profiled in this report include Boston Scientific Corporation, Medtronic Plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation, AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, and Vascular Solutions, Inc.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.